|
|
|
Volumn 36, Issue 3, 2001, Pages
|
|
Pharmacologic therapy for the treatment and prevention of osteoporosis.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
CALCITONIN;
DRUG DERIVATIVE;
ETIDRONIC ACID;
RALOXIFENE;
RISEDRONIC ACID;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
AGED;
BONE DENSITY;
DRUG EFFECT;
ESTROGEN THERAPY;
FEMALE;
FRACTURE;
HUMAN;
MALE;
METHODOLOGY;
MIDDLE AGED;
OSTEOPOROSIS;
PATIENT COMPLIANCE;
PATIENT SELECTION;
PRIMARY PREVENTION;
PSYCHOLOGICAL ASPECT;
REVIEW;
RISK FACTOR;
TREATMENT OUTCOME;
AGED;
ALENDRONATE;
BONE DENSITY;
CALCITONIN;
DIPHOSPHONATES;
ESTROGEN REPLACEMENT THERAPY;
ETIDRONIC ACID;
FEMALE;
FRACTURES, BONE;
HUMANS;
MALE;
MIDDLE AGED;
OSTEOPOROSIS;
PATIENT COMPLIANCE;
PATIENT SELECTION;
PRIMARY PREVENTION;
RALOXIFENE;
RISK FACTORS;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
TREATMENT OUTCOME;
|
|
EID: 0035461398
PISSN: 00296465
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (11)
|
|
References (30)
|
